Pyronaridine: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
== Pyronaridine == | |||
[[File:Pyronaridine.svg|thumb|right|Chemical structure of Pyronaridine]] | |||
'''Pyronaridine''' is an antimalarial drug used in the treatment of [[malaria]], a disease caused by [[Plasmodium]] parasites. It is particularly effective against the [[Plasmodium falciparum]] and [[Plasmodium vivax]] species. Pyronaridine is often used in combination with other antimalarial agents to enhance efficacy and reduce the risk of resistance. | |||
== | == History == | ||
Pyronaridine was first synthesized in the 1970s in China. It was developed as part of efforts to find new treatments for malaria, which was a significant public health issue in many parts of the world. The drug was initially used in China and later introduced to other countries where malaria is endemic. | |||
== | == Mechanism of Action == | ||
== | Pyronaridine works by interfering with the parasite's ability to detoxify heme, a byproduct of hemoglobin digestion. The accumulation of toxic heme within the parasite leads to its death. This mechanism is similar to that of other antimalarial drugs such as [[chloroquine]]. | ||
Pyronaridine, | |||
== Pharmacokinetics == | |||
Pyronaridine is administered orally and is well absorbed from the gastrointestinal tract. It is metabolized in the liver and excreted primarily in the urine. The drug has a long half-life, which allows for once-daily dosing in combination therapies. | |||
== Clinical Use == | |||
Pyronaridine is used in combination with [[artesunate]], another antimalarial drug, in a fixed-dose combination known as pyronaridine-artesunate. This combination is effective against both uncomplicated and severe malaria. The combination therapy is preferred because it reduces the likelihood of resistance development and provides a synergistic effect against the malaria parasite. | |||
== Side Effects == | |||
Common side effects of pyronaridine include headache, dizziness, and gastrointestinal disturbances such as nausea and vomiting. In rare cases, it may cause liver enzyme elevations, which necessitates monitoring in patients with pre-existing liver conditions. | |||
== Resistance == | |||
Resistance to pyronaridine is relatively rare, but as with all antimalarial drugs, there is a risk of resistance developing over time. The use of combination therapies helps to mitigate this risk by attacking the parasite through multiple mechanisms. | |||
== Related Pages == | |||
* [[Malaria]] | |||
* [[Plasmodium falciparum]] | |||
* [[Plasmodium vivax]] | |||
* [[Antimalarial medication]] | |||
* [[Artesunate]] | |||
[[Category:Antimalarial agents]] | [[Category:Antimalarial agents]] | ||
[[Category:Pharmacology]] | [[Category:Pharmacology]] | ||
Latest revision as of 11:14, 23 March 2025
Pyronaridine[edit]
Pyronaridine is an antimalarial drug used in the treatment of malaria, a disease caused by Plasmodium parasites. It is particularly effective against the Plasmodium falciparum and Plasmodium vivax species. Pyronaridine is often used in combination with other antimalarial agents to enhance efficacy and reduce the risk of resistance.
History[edit]
Pyronaridine was first synthesized in the 1970s in China. It was developed as part of efforts to find new treatments for malaria, which was a significant public health issue in many parts of the world. The drug was initially used in China and later introduced to other countries where malaria is endemic.
Mechanism of Action[edit]
Pyronaridine works by interfering with the parasite's ability to detoxify heme, a byproduct of hemoglobin digestion. The accumulation of toxic heme within the parasite leads to its death. This mechanism is similar to that of other antimalarial drugs such as chloroquine.
Pharmacokinetics[edit]
Pyronaridine is administered orally and is well absorbed from the gastrointestinal tract. It is metabolized in the liver and excreted primarily in the urine. The drug has a long half-life, which allows for once-daily dosing in combination therapies.
Clinical Use[edit]
Pyronaridine is used in combination with artesunate, another antimalarial drug, in a fixed-dose combination known as pyronaridine-artesunate. This combination is effective against both uncomplicated and severe malaria. The combination therapy is preferred because it reduces the likelihood of resistance development and provides a synergistic effect against the malaria parasite.
Side Effects[edit]
Common side effects of pyronaridine include headache, dizziness, and gastrointestinal disturbances such as nausea and vomiting. In rare cases, it may cause liver enzyme elevations, which necessitates monitoring in patients with pre-existing liver conditions.
Resistance[edit]
Resistance to pyronaridine is relatively rare, but as with all antimalarial drugs, there is a risk of resistance developing over time. The use of combination therapies helps to mitigate this risk by attacking the parasite through multiple mechanisms.
